MUMBAI, India, Jan. 2 -- Intellectual Property India has published a patent application (202541123144 A) filed by B V Raju Institute Of Technology, Narsapur, Telangana, on Dec. 6, 2025, for 'pancreascan: a cnn-based system for high-precision pancreatic cancer screening.'
Inventor(s) include K. Saimadhuri; Durgadevi Seetha; Cheemaladinne Vengaiah; and Sreekanth Kota.
The application for the patent was published on Jan. 2, under issue no. 01/2026.
According to the abstract released by the Intellectual Property India: "Early detection of pancreatic cancer remains one of the most challenging tasks in clinical oncology due to the disease's deep anatomical location, subtle early-stage symptoms, and rapid progression. PancreaScan is proposed as a high-precision, deep-learning-driven screening system designed to support radiologists in identifying pancreatic abnormalities at an early stage. The system employs a customized Convolutional Neural Network (CNN) architecture optimized for analyzing CT and MRI abdominal scans, integrating multi-scale feature extraction and attention mechanisms to capture minute textural and structural variations associated with tumor development. A curated dataset of annotated medical images was used to train and validate the model, achieving high sensitivity and specificity in distinguishing malignant, benign, and healthy pancreatic tissues. Experimental results demonstrate that PancreaScan outperforms several baseline CNN architectures, delivering robust classification accuracy even in complex imaging conditions. The study highlights the potential of CNN-based automated screening tools to significantly reduce diagnostic delays, enhance clinical workflow efficiency, and ultimately improve patient outcomes in pancreatic cancer care."
Disclaimer: Curated by HT Syndication.
